Successful treatment of primary refractory DLBCL/HGBL – MYC/BCL2 transformed from FL using glofitamab: a case report
Diffuse large B-cell lymphoma/high-grade B-cell lymphoma with MYC and BCL2 rearrangements (DLBCL/HGBL-MYC/BCL2) represents a distinct entity of mature aggressive B-cell lymphoma, constituting a substantial gap in the clinical management of DLBCL. Conve…